THE RELATIONSHIP BETWEEN THE LEVEL OF INTERLEUKIN-6 AND PROCALCITONIN IN SEVERE SEPSIS PATIENTS AT THE ADAM MALIK HOSPITAL
DOI:
https://doi.org/10.24293/ijcpml.v25i1.1488Keywords:
Severe sepsis, interleukin-6, procalcitoninAbstract
Severe sepsis is defined as sepsis that is accompanied by one or more organ dysfunctions, hypotension or hypoperfusion (decreased renal function, hypoxemia, lactic acidosis, oliguria, mental status changes). Macrophages and monocytes produced Procalcitonin (PCT) in serious bacterial infections and sepsis. Interleukin-6 (IL-6) is an interleukin that acts as proinflammatory cytokines. The high IL-6 level is due to chronic inflammation and sepsis. IL-6 is found increased more rapidly in the acute phase, so it can be used to evaluate early phase infection and sepsis. The purpose of this study was to find out IL-6 and PCT levels in severe sepsis patients. This study was a cross-sectional observational study. The subjects were sepsis patients treated in Adam Malik Hospital on Jan-Mar 2016. Statistical data was analyzed using SPSS and the Spearman rank correlation, with significant p-value < 0.05. IL-6 was tested using Chem Well 9210 series. Procalcitonin examination was done by mini VIDAS BRAHMS PCT. There were 40 people observed as subjects in this study, 26 males (65%) and 14 females (35%). The average age of male was 49.42 ± 18.19 years old, the youngest 18 years old, and the oldest 79 years old. The average age of females 57.35 ± 20.73, the youngest 18 years old, and the oldest 87 years old. The average of IL-6 was 10862.12 ± 25489.16 and PCT was 9666.73 ± 10540.13. Spearman rank test was also used, the value of r = 0.176 and p = 0.277. The conclusion is there is no significant correlation between IL-6 and PCT. There is no significant correlation between IL-6 and PCT levels in severe sepsis patients.
Downloads
References
Toro RJJ, Marquez CM, Garcia JMA, Martin AA, Rivera FR, Benito DSA, Antonio GJ, Gonzalez). Soluble membrane receptors, interleukin 6, PCT and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. Plos One, 2017; 12(4): e0175254.
Angus DC, Van Der Poll T. Severe sepsis and septic shock. N Engl J Med, 2013; 369(9): 840-851.
Tetsuya T, Kinoshita T. GP130 and the interleukin-6 family of cytokines. Annual Review Immunology, 2017; 15: 797-819.
Daniel RG, Gerald B, Copeland S, Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun, 2015; 73: 2751-2757.
Wu J, HU L, Zhang G, Wu F, He T. Accuracy of presepsin in sepsis diagnosis: A systematic review and meta-analysis. Plos One, 2015; 10(7): e0133057.
Christina W, Anna P, Frank MB, Peter S. Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis. Lancet Infect Dis, 2013; 13: 426-435.
Fang FB, Wu Ye, Zhang LC. Variation in the levels of IL-6 in pediatric patients with severe bacterial infectious diseases and correlation analysis between the levels of IL-6 and PCT. Experimental and Therapeutic Medicine, 2017; 13: 3484-3488.
Francis L, Leteurtre S, Duhamel A, Bruno G, Francois P, Alain M, France, Hubert P and Jacques L. Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am J Respiratory Critical Care Med, 2005; 171: 348 353.
Takashi T, Akira S, Yoshida K, Masanori U, Yoshihiro Y, Naoki S, Fujiwara H, Sachiko S, Yoshida N and Kishimoto T. Targeted disruption of the NF IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell, 2015; 80: 353 361.
Christina W, Anna P, Frank MB, Peter S. Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis. Lancet Infect Dis, 2013; 13: 426-435.
Riedel S, Carroll KC. Laboratory detection of sepsis. Biomarkers and molecular approaches. Clinical Lab Med, 2013; 33: 413-437.
Wong HR,Walley KR, Pettila V, Meyer NJ, Russell JA, Karlsson S, Shashaty MG, Lindsell CJ. Comparing the prognostic performance of assist to interleukin-6 and procalcitonin in patients with severe sepsis or septic shock. Biomarkers. 2015; 20(2): 132 -5.
Hou T, Huang D, Zhang R, Ye Z, Zhang Y. Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis. International Journal Clinical Exp Med, 2015; 8(9): 15238-15245.
Wu Y, Wang M, Zhu Y, Lin S. Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients. Medicine, 2016; 95: 41.
Olivier LM, Jacques D, Jeanne MD, Alain C, Francois D, Jacques B, Michel G, Jean PB. Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. Journal of Hepatology, 2014; 20: 819–24.
Mat-nor MB, Ralib A, Abdullah ZN, Pickering JW. The diagnostic ability of PCT and interleukin-6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care, 2016; 33: 245-51.
